Across TCGA pan-cancer cohorts, RNU6-686P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6-686P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RNU6-686P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-686P is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

COAD and THCA are the cancer types where RNU6-686P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-686P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	−0.078	.022	2	view →
THCA	Male	All	−0.174	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-686P RNA expression & survival · all RNU6-686P data types